Nisa Investment Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34K Hold
142
﹤0.01% 2812
2026
Q1
$1.3K Buy
142
+20
+16% +$168 ﹤0.01% 2699
2025
Q4
$908 Hold
122
﹤0.01% 2725
2025
Q3
$816 Buy
+122
New +$847 ﹤0.01% 2776
2025
Q2
Sell
-159
Closed -$1.46K 3046
2025
Q1
$1.46K Buy
159
+61
+62% +$609 ﹤0.01% 2542
2024
Q4
$1.03K Hold
98
﹤0.01% 2675
2024
Q3
$1.17K Buy
+98
New +$847 ﹤0.01% 2538
2024
Q2
Sell
-86
Closed -$447 2941
2024
Q1
$447 Hold
86
﹤0.01% 2518
2023
Q4
$453 Hold
86
﹤0.01% 2430
2023
Q3
$284 Hold
86
﹤0.01% 2620
2023
Q2
$249 Buy
+86
New +$165 ﹤0.01% 2686
2023
Q1
Sell
-75
Closed 2542
2022
Q4
$0 Buy
+75
New +$327 ﹤0.01% 2589

Other funds holding BVS

Nisa Investment Advisors's BVS Position: Q2 2026 in Review

Nisa Investment Advisors held its Bioventus (BVS) position steady in Q2 2026 at 142 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Nisa Investment Advisors first reported a position in BVS in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.46K in Q1 2025. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Nisa Investment Advisors held 142 shares of Bioventus worth $1.34K as of Q2 2026.
  • Nisa Investment Advisors left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2812 holding.
  • Nisa Investment Advisors first reported a position in Bioventus in Q4 2022 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Bioventus position peaked at $1.46K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.